The Stanford Molecular Imaging Scholars (SMIS) program is an integrated, three-year cross-disciplinary postdoctoral training program at Stanford University that brings together 33 faculty mentors from 14 departments in the Schools of Medicine, Engineering, and Humanities and Sciences. Molecular imaging, the non-invasive monitoring of specific molecular and biochemical processes in living organisms, continues to expand its applications in the detection and management of cancer. We propose to train, on average, 8 postdoctoral trainees per year (comprising 1st, 2nd, and 3rd year fellows). SMIS faculty mentors provide a diverse training environment spanning biology, physics, mathematics, biocomputation/biomedical informatics, engineering, chemistry, biochemistry, cancer biology, immunology, and medical sciences. The centerpiece of the SMIS program is the opportunity for trainees (PhD or MD with an emphasis on PhD) to conduct innovative molecular imaging research that is co-mentored by faculty in complementary disciplines. SMIS trainees also engage in specialized coursework, seminars, national conferences, clinical rounds, including ethics training and the responsible conduct of research. The three-year program culminates with the preparation and review of a mock NIH grant proposal, in support of trainee transition to an independent career in cancer molecular imaging. During the first two award cycles 28 trainees have entered the SMIS program; 6 are currently enrolled and 22 have completed the program as of this writing. Those who have moved on are either in faculty positions, other academic positions, or working in biotechnology. Demand for the SMIS training is high; we now receive, on average, more than 20 applications per year from qualified candidates seeking placement in our program, which can accommodate only 2-4 new trainees per year. For the upcoming cycle, we propose an enriched SMIS program that achieves the following: expansion of our Program Area in Chemistry of Molecular Probes; strategic selection of additional faculty mentors; improvement in all other training and career development components; expansion of leadership for our mock grant proposal activity and our clinical exposure component; and recruitment and retention of underrepresented minority candidates. The goal of the SMIS program is to continue to provide talented young investigators with the scientific and professional education/career development opportunities to become leaders in the field of molecular imaging of cancer.

Public Health Relevance

The Stanford Molecular Imaging Scholars (SMIS) program is an integrated, cross-disciplinary postdoctoral training program that prepares young investigators for research careers in the field of molecular imaging of cancer. Molecular imaging is a science that allows visualization of specific molecular and biochemical processes in intact living organisms, and provides powerful tools for the study of disease. SMIS trainees develop innovative molecular imaging approaches for the diagnosis and management of cancer, including the development of novel probes, guiding the selection and/or discovery of novel treatments, and evaluation of therapy response.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
3T32CA118681-11A1S1
Application #
9440617
Study Section
Subcommittee F - Institutional Training and Education (NCI-F)
Program Officer
Lim, Susan E
Project Start
2016-09-01
Project End
2021-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
11
Fiscal Year
2017
Total Cost
$1,535
Indirect Cost
$113
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Kiru, Louise; Kim, Tae Jin; Shen, Bin et al. (2018) Single-Cell Imaging Using Radioluminescence Microscopy Reveals Unexpected Binding Target for [18F]HFB. Mol Imaging Biol 20:378-387
Kim, Tae Jin; Jung, Kyung Oh; Fahimian, Benjamin et al. (2018) Flexible optically stimulated luminescence band for 1D in vivo radiation dosimetry. Phys Med Biol 63:165006
Tummers, Willemieke S; Miller, Sarah E; Teraphongphom, Nutte T et al. (2018) Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. Ann Surg Oncol 25:1880-1888
Wang, Qian; Sengupta, Debanti; Kim, Tae Jin et al. (2018) In silico optimization of radioluminescence microscopy. J Biophotonics 11:
Sengupta, Debanti; Kim, Tae Jin; Almasi, Sepideh et al. (2018) Development and characterization of a scintillating cell imaging dish for radioluminescence microscopy. Analyst 143:1862-1869
Cates, Joshua W; Levin, Craig S (2018) Evaluation of a clinical TOF-PET detector design that achieves ?100 ps coincidence time resolution. Phys Med Biol 63:115011
Mohanty, Suchismita; Chen, Zixin; Li, Kai et al. (2017) A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. Mol Cancer Ther 16:1909-1921
Kim, Tae Jin; Türkcan, Silvan; Pratx, Guillem (2017) Modular low-light microscope for imaging cellular bioluminescence and radioluminescence. Nat Protoc 12:1055-1076
Cates, Joshua W; Bieniosek, Matthew F; Levin, Craig S (2017) Highly multiplexed signal readout for a time-of-flight positron emission tomography detector based on silicon photomultipliers. J Med Imaging (Bellingham) 4:011012
Aghighi, Maryam; Pisani, Laura; Theruvath, Ashok J et al. (2017) Ferumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection. Mol Imaging Biol :

Showing the most recent 10 out of 14 publications